
Christoph von der Goltz, PhD
VP, Global Head of Medicine CNS & Emerging Areas
Boehringer Ingelheim
Board certified psychiatrist with broad clinical experience in neurology and psychiatry and academic research in pre-clinical, clinical and public health projects. In the pharmaceutical industry extensive R&D leadership experience across different global roles in Medical Affairs, Health Economics, Real World Evidence and Clinical Development in CNS. Successfully built, led and transformed departments and cross-functional matrix teams. Used to work in a global and innovation-oriented environment from translational medicine to later stage development incl. life cycle management and value evidence generation strategies.